Assenagon Asset Management S.A.
Position in ANIK — Anika Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in ANIK
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$921,924
+$246,427 QoQ
Shares Held
63,016
+35.3% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 8 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. ANIK ranks #16 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in ANIK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $921,924 | 63,016 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $675,497 | 46,586 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $121,422 | 12,635 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $430,924 | 45,843 | Shares | Sole | 2025-10-07 | |
| 2024-09-30 | $1,253,401 | 50,745 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,190,813 | 47,012 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,194,104 | 47,012 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,065,563 | 47,024 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $876,057 | 47,024 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,221,683 | 47,024 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,350,529 | 47,024 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,411,801 | 47,696 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $2,143,261 | 90,053 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,009,982 | 90,053 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,308,236 | 91,925 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,640,092 | 129,503 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $11,496,349 | 270,121 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $7,836,399 | 181,021 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,942,582 | 47,624 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $1,868,694 | 41,288 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $2,441,910 | 69,000 | Shares | Sole | 2020-10-07 | |
| 2020-03-31 | $2,852,549 | 98,670 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||